Homodimerization as a molecular switch between low and high efficiency PrP C cell surface delivery and neuroprotective activity.
PrP (C) is associated with a variety of functions, and its ability to interact with a multitude of partners, including itself, may largely explain PrP multifunctionality and the lack of consensus on the genuine physiological function of the protein in vivo. In contrast, there is a consensus in the literature that alterations in PrP (C) trafficking and intracellular retention result in neuronal degeneration. In addition, a proteolytic modification in the late secretory pathway termed the α-cleavage induces the secretion of PrPN1, a PrP (C) -derived metabolite with fascinating neuroprotective activity against toxic oligomeric Aβ molecules implicated in Alzheimer disease. Thus, studies focusing on understanding the regulation of PrP (C) trafficking to the cell surface and the modulation of α-cleavage are essential. The objective of this commentary is to highlight recent evidences that PrP (C) homodimerization stimulates trafficking of the protein to the cell surface and results in high levels of PrPN1 secretion. We also discuss a hypothetical model for these results and comment on future challenges and opportunities.
Department of Biochemistry, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC Canada.
Maxime
M
Béland
Xavier
X
Roucou
D000818:Animals; D002417:Cattle; D002462:Cell Membrane / Q000378:metabolism; D006224:Cricetinae; D006801:Humans; D051379:Mice; D008954:Models, Biological; D018696:Neuroprotective Agents / Q000737:chemistry* / Q000378:metabolism*; D018621:PrPC Proteins / Q000737:chemistry* / Q000378:metabolism*; D055503:Protein Multimerization
D018696:Neuroprotective Agents; D018621:PrPC Proteins
Alzheimer disease; dimerization; neuroprotection; prion; protein secretion; β-sheet oligomers